|
The leading provider of healthcare intelligence and quality improvement services.
Accessibility
Reasons to choose CHKS
We have strong relationships with organisations including ISQua, Picker Institute, NHS Elect, York Health Economics Consortium and the Association of Public Health Observatories.
HSJ January 2010
The chancellor's pre-Budget report has promised a real-term increase in funding for 2010-11 on 95 per cent of NHS spending. However, this only applies to the cash element of the NHS allocation and there is a gap between this and total funding of £8.6bn which has yet to be confirmed.
Analysis of the data set which Hospital Standardised Mortality Ratios (HSMRs) are based on raises questions about its suitability for this purpose. HSMRs rely on an assumption that the data set is uniform and consistent over time. This analysis shows that it has been both changing over time and varies between organisations - creating problems for the interpretation of HSMRs and is therefore a call for improved and consistent coding of hospital activity.
HSJ February 2009
This report looks at the issue of Consultant to Consultant (C2C) referrals for outpatient attendances in England. It highlights the increasing proportion of such referrals over the last five years and the high level of variation between providers.
HSJ February 2009
Exploring the World Class Commissioning data pack highlighted variations in antidepressant prescribing. This was found to be related to ethnicity, and surprisingly, completed unrelated to the availability of talking therapies. Given that access to psychological therapies (talking therapies) is one of the few tools available to commissioners the early signs are that it is not being used in a very systematic fashion.
HSJ December 2008
Work carried out for a client found that end of life care was being significantly under-recorded. Further examination has shown that this is likely to be happening in all trusts. There are major implications for commissioners developing end of life care strategies and risk adjustment models for mortality. It also raises some questions about the measurement of potential improvements in length of stay.